血栓性
医学
血栓调节蛋白
突变
凝血病
凝结
血栓形成
凝血酶
蛋白质C
抗凝血酶
止血
因子V
内科学
胃肠病学
免疫学
遗传学
生物
基因
肝素
血小板
作者
Xi Wu,Lei Li,Zhengjing Lu,Xiaobo Hu,Yeling Lu,Yu Liu,Guan-qun Xu,Qiulan Ding,Xuefeng Wang,Wenman Wu,Peipei Jin,Jing Dai
出处
期刊:Thrombosis and Haemostasis
[Georg Thieme Verlag KG]
日期:2024-06-24
摘要
Background Venous thromboembolism (VTE) is predisposed by thrombotic mutations in patients with hereditary thrombophilia. Although prothrombin deficiencies caused by homozygous or compound heterozygous mutations are associated with bleeding diathesis, rare cases have shown a correlation between heterozygous prothrombin mutations and thrombosis. Materials and Methods We surveyed genetic variants involved in thrombosis and hemostasis in 347 patients with unprovoked VTE or having a positive family history of thrombosis. For patients identified with heterozygous prothrombin mutations, we conducted family investigations and performed a thrombin generation test (TGT) to elucidate the thrombotic risk. Novel mutants were expressed and subjected to functional assays to clarify the underlying thrombotic mechanisms. Results Heterozygous prothrombin mutations were identified in 3.5% of patients (12/347), including three novel mutations Phe382Ser, Phe382Leu, and Asp597Tyr found in one patient each, as well as previously reported Arg541Trp mutation in four patients and Arg596Gln mutation in five patients. A total of 42 mutation carriers were identified within the 12 pedigrees, among whom 64.3% (27/42) had experienced thrombotic events. TGT results demonstrated hypercoagulability for carriers of the five mutations, with Arg596Gln showing the highest thrombin generation potential followed by Arg541Trp. The Phe382-associated mutations severely impaired thrombomodulin-binding ability of thrombin, resulting in obviously reduced protein C (PC) activation. The Asp597Tyr mutation exhibited a mild reduction in both inactivation by antithrombin and PC activation reactions. Conclusion The presence of heterozygous prothrombin mutations represents a potential genetic predisposition for VTE. All thrombosis-associated mutations potentiate coagulation activity by either conferring antithrombin resistance and/or impairing PC pathway activity.
科研通智能强力驱动
Strongly Powered by AbleSci AI